Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma
Status:
Recruiting
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
This is an open label phase II pilot study assessing the metabolomic and inflammatory effects
of oral aspirin (ASA) in human subjects at risk for melanoma.